document.write("
"); document.write("
Zhou,\ J.*\ ; He,\ M.*\ ; Zhao,\ Q.*\ ; Shi,\ E.*\ ; Wang,\ H.*\ ; Ponkshe,\ V.*\ ; Song,\ J.*\ ; Wu,\ Z.*\ ; Ji,\ D.*\ ; Kranz,\ G.*\ ; Tscherne,\ A.*\ ; Schwenk-Zieger,\ S.*\ ; Razak,\ N.A.*\ ; Hess J.\ ; Belka,\ C.*\ ; Zitzelsberger,\ H.\ ; Ourailidis,\ I.*\ ; Stögbauer,\ F.*\ ; Boxberg,\ M.*\ ; Budczies,\ J.*\ ; Reichel,\ C.A.*\ ; Canis,\ M.*\ ; Baumeister,\ P.*\ ; Unger,\ K.\ ; Mock,\ A.*\ ; Gires,\ O.*
"); document.write("
EGFR-mediated local invasiveness and response to Cetuximab in head and neck cancer.
"); document.write("
Mol. Cancer 24:94 (2025)
"); document.write("
"); document.write("
"); document.write("
Bahrami,\ E.\ ; Schmid,\ J.P.\ ; Jurinovic,\ V.\ ; Becker,\ M.\ ; Wirth,\ A.-K.\ ; Ludwig,\ R.\ ; Kreissig,\ S.*\ ; Duque Angel,\ T.V.\ ; Amend,\ D.\ ; Hunt,\ K.\ ; Öllinger,\ R.*\ ; Rad,\ R.*\ ; Frenz,\ J.M.*\ ; Solovey,\ M.\ ; Ziemann,\ F.*\ ; Mann,\ M.*\ ; Vick,\ B.\ ; Wichmann,\ C.*\ ; Herold,\ T.\ ; Jayavelu,\ A.K.*\ ; Jeremias,\ I.
"); document.write("
Combined proteomics and CRISPR‒Cas9 screens in PDX identify ADAM10 as essential for leukemia in vivo.
"); document.write("
Mol. Cancer 22:107 (2023)
"); document.write("
"); document.write("
"); document.write("
Schinke,\ H.*\ ; Shi,\ E.*\ ; Lin,\ Z.*\ ; Quadt,\ T.*\ ; Kranz,\ G.*\ ; Zhou,\ J.*\ ; Wang,\ H.*\ ; Hess J.\ ; Heuer,\ S.\ ; Belka,\ C.\ ; Zitzelsberger,\ H.\ ; Schumacher,\ U.*\ ; Genduso,\ S.*\ ; Riecken,\ K.*\ ; Gao,\ Y.*\ ; Wu,\ Z.*\ ; Reichel,\ C.A.*\ ; Walz,\ C.*\ ; Canis,\ M.*\ ; Unger,\ K.\ ; Baumeister,\ P.\ ; Pan,\ M.*\ ; Gires,\ O.
"); document.write("
A transcriptomic map of EGFR-induced epithelial-to-mesenchymal transition identifies prognostic and therapeutic targets for head and neck cancer.
"); document.write("
Mol. Cancer 21:178 (2022)
"); document.write("
"); document.write("
"); document.write("
Müller,\ S.*\ ; Raulefs,\ S.*\ ; Bruns,\ P.*\ ; Afonso-Grunz,\ F.*\ ; Plötner,\ A.*\ ; Thermann,\ R.*\ ; Jager,\ C.*\ ; Schlitter,\ A.M.*\ ; Kong,\ B.*\ ; Regel,\ I.*\ ; Roth,\ W.K.*\ ; Rotter,\ B.*\ ; Hoffmeier,\ K.*\ ; Kahl,\ G.F.*\ ; Koch,\ I.*\ ; Theis,\ F.J.\ ; Kleeff,\ J.*\ ; Winter,\ P.*\ ; Michalski,\ C.W.*
"); document.write("
Next-generation sequencing reveals novel differentially regulated mRNAs, lncRNAs, miRNAs, sdRNAs and a piRNA in pancreatic cancer.
"); document.write("
Mol. Cancer 14:94 (2015)
"); document.write("
"); document.write("
"); document.write("
Müller,\ S.*\ ; Raulefs,\ S.*\ ; Bruns,\ P.*\ ; Afonso-Grunz,\ F.*\ ; Plötner,\ A.*\ ; Thermann,\ R.*\ ; Jager,\ C.*\ ; Schlitter,\ A.M.*\ ; Kong,\ B.*\ ; Regel,\ I.*\ ; Roth,\ W.K.*\ ; Rotter,\ B.*\ ; Hoffmeier,\ K.*\ ; Kahl,\ G.F.*\ ; Koch,\ I.*\ ; Theis,\ F.J.\ ; Kleeff,\ J.*\ ; Winter,\ P.*\ ; Michalski,\ C.W.*
"); document.write("
Erratum to: Next-generation sequencing reveals novel differentially regulated mRNAs, lncRNAs, miRNAs, sdRNAs and a piRNA in pancreatic cancer.
"); document.write("
Mol. Cancer 14:144 (2015)
"); document.write("
"); document.write("
"); document.write("
di Maro,\ G.*\ ; Salerno,\ P.*\ ; Unger,\ K.*\ ; Orlandella,\ F.M.*\ ; Monaco,\ M.*\ ; Chiappetta,\ G.*\ ; Thomas,\ G.*\ ; Oczko-Wojciechowska,\ M.*\ ; Masullo,\ M.*\ ; Jarzab,\ B.*\ ; Santoro,\ M.*\ ; Salvatore,\ G.*
"); document.write("
Anterior gradient protein 2 promotes survival, migration and invasion of papillary thyroid carcinoma cells.
"); document.write("
Mol. Cancer 13:160 (2014)
"); document.write("
"); document.write("
"); document.write("
Rosemann,\ M.\ ; Gonzalez-Vasconcellos,\ I.\ ; Domke,\ T.\ ; Kuosaite,\ V.\ ; Schneider,\ R.\ ; Kremer,\ M.\ ; Favor,\ J.\ ; Nathrath,\ M.\ ; Atkinson,\ M.J.
"); document.write("
A \Rb1\ promoter variant with reduced activity contributes to osteosarcoma susceptibility in irradiated mice.
"); document.write("
Mol. Cancer 13:182 (2014)
"); document.write("
"); document.write("
"); document.write("
Ludyga,\ N.\ ; Englert,\ S.\ ; Pflieger,\ K.\ ; Rauser,\ S.\ ; Braselmann,\ H.\ ; Walch,\ A.K.\ ; Auer,\ G.*\ ; Höfler,\ H.\ ; Aubele,\ M.
"); document.write("
The impact of Cysteine-Rich Intestinal Protein 1 (CRIP1) in human breast cancer.
"); document.write("
Mol. Cancer 12:28 (2013)
"); document.write("
"); document.write("
"); document.write("
Jantscher,\ F.*\ ; Pirker,\ C.*\ ; Mayer,\ C.E.\ ; Berger,\ W.*\ ; Sutterluety,\ H.*
"); document.write("
Overexpression of Aurora-A in primary cells interferes with S-phase entry by diminishing Cyclin D1 dependent activities.
"); document.write("
Mol. Cancer 10:28 (2011)
"); document.write("
"); document.write("
"); document.write("
Molatore,\ S.\ ; Kiermaier,\ E.\ ; Jung,\ C.B.\ ; Lee,\ M.S.\ ; Pulz,\ E.\ ; Höfler,\ H.\ ; Atkinson,\ M.J.\ ; Pellegata,\ N.S.
"); document.write("
Characterization of a naturally-occurring p27 mutation predisposing to multiple endocrine tumors.
"); document.write("
Mol. Cancer 9:116 (2010)
"); document.write("
");